Immediate Impact
2 by Nobel laureates 4 from Science/Nature 59 standout
Citing Papers
Type 1 diabetes
2023 Standout
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
2023 Standout
Works of Steve Shuey being referenced
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Steve Shuey | 151 | 66 | 177 | 245 | 153 | 5 | 423 | |
| G. Tolksdorf | 247 | 75 | 120 | 240 | 147 | 9 | 497 | |
| Eileen Sussman | 182 | 31 | 67 | 281 | 125 | 9 | 402 | |
| T Beck | 71 | 22 | 123 | 261 | 146 | 5 | 382 | |
| G Wong | 97 | 106 | 81 | 181 | 121 | 10 | 389 | |
| Nicole Adrian | 129 | 84 | 110 | 189 | 65 | 10 | 421 | |
| E. Emmett | 216 | 48 | 71 | 267 | 331 | 7 | 444 | |
| BM Wilkes | 204 | 51 | 45 | 244 | 186 | 8 | 410 | |
| Baha Alkuzweny | 94 | 24 | 125 | 363 | 178 | 7 | 450 | |
| Marie-Elisabeth Goebeler | 106 | 38 | 99 | 194 | 65 | 7 | 381 | |
| Justus Duyster | 140 | 143 | 100 | 168 | 69 | 11 | 482 |
All Works
Loading papers...